RxDoctor Payments Data

Melissa Smith

Family · Englewood, CONPI 1194363093

Payments from drug & device makers

$1,782in general payments, 2019–2025

Across 88 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$409
  • Medtronic$292
  • Lilly USA, LLC$147
  • Takeda Pharmaceuticals U.S.A., Inc.$112
  • AbbVie$110
  • Merck$95
  • plus $618 from 16 others

What the payments were for

  • Food & beverage$1,782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,782 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide36$34,079
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$22,967
MounjaroTirzepatide14$15,574
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$11,011
JardianceEmpagliflozin24$7,578
ArexvyRsvpref3 Antigen/As01e/Pf17$5,085
EliquisApixaban14$3,887
LantusInsulin Glargine,hum.Rec.Anlog43$3,786
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen94$2,672
MyrbetriqMirabegron11$2,605
Aripiprazole26$1,861
ValacyclovirValacyclovir Hcl15$1,729
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$1,310
Sertraline Hcl71$1,259
Gabapentin38$1,119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$147$49,65450 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy$37$39,06372 claims
Boehringer IngelheimJardiance$19$7,57824 claims
Sanofi-aventis U.S. LLCLantus$14$3,78643 claims
Almatica Pharma LLCSertraline Hcl$24$1,25971 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,182 family providers in Colorado.

Other family in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →